Results 151 to 160 of about 10,597 (237)

Benefits of Antifibrinolytics in Minimally Invasive Surgical Repair of Single-suture Craniosynostosis. [PDF]

Plast Reconstr Surg Glob Open
Rodriguez GC, Bajaj A, Rai P, Gamble MA, George E, Qureshi U, Hallman TG, Gosain AK.   +7 more
europepmc   +1 more source

2024 Guidelines on Patient Blood Management for Adult Cardiac Surgery Under Cardiopulmonary Bypass in China. [PDF]

Rev Cardiovasc Med
Yan S, Zhou L, Chen C, Teng Y, Liu G, Bian L, Su J, Ji H, Hei F, Wang S, Wang G, Ao H, Du L, Zhou C, Ji B, Nccqi OBOTWGOCOC.   +15 more
europepmc   +1 more source

Unveiling the role of lipid metabolism in haemorrhagic disorders: genetic insights and therapeutic perspectives. [PDF]

Thromb J
Wei J, Yang Z, Wu X, Zheng N, Wu D.
europepmc   +1 more source

Managing Oral Surgery in von Willebrand Disease: Lessons from a Challenging Case. [PDF]

J Clin Exp Dent
Ascani G, Ranalli P, Azzuni F, Benfatto S, Romano M, Di Nobile E.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Comparison of effectiveness and safety of epsilon-aminocaproic acid and tranexamic acid in adult patients undergoing cardiac surgery

Journal of Medical Society, 2022
Objective: The objective of the study is to evaluate the effectiveness and safety of epsilon-aminocaproic acid (EACA) and tranexamic acid (TXA) in reducing bleeding, re-exploration, and blood transfusion in patients who underwent a cardiac surgical ...
L. Singh, Sanjeev Singh, I. Okyere, Anbarasu Annamalai, Arti Singh   +4 more
semanticscholar   +1 more source

Epsilon-Aminocaproic Acid (EACA)

Seminars in Thrombosis and Hemostasis, 2008
Epsilon-aminocaproic acid (EACA) is a synthetic inhibitor of the plasmin-plasminogen system. It is the only potent antifibrinolytic agent which is commercially available in the United States. Effective blood levels of the drug are readily obtainable with either oral or intravenous administration, with very high levels of the drug being found in the ...
J D, Griffin, L, Ellman
openaire   +2 more sources

Tranexamic acid or epsilon-aminocaproic acid in total joint arthroplasty? A randomized controlled trial.

The Bone & Joint Journal, 2019
AIMS Antifibrinolytic agents, including tranexamic acid (TXA) and epsilon-aminocaproic acid (EACA), have been shown to be safe and effective for decreasing perioperative blood loss and transfusion following total hip arthroplasty (THA) and total knee ...
Kendall E Bradley, Sean P. Ryan, Colin T. Penrose, Stuart A. Grant, S. Wellman, D. Attarian, C. Green, T. Risoli, M. Bolognesi   +8 more
semanticscholar   +1 more source

Thrombosis with Epsilon Aminocaproic Acid Therapy

American Journal of Clinical Pathology, 1971
A patient with postoperative bleeding was treated with epsilon aminocaproic acid (EACA). Subsequent coagulation studies supported the diagnosis of intravascular coagulation and the patient subsequently developed renal failure due to glomerular thromboses.
H R, Gralnick, P, Greipp
openaire   +2 more sources